Unknown

Dataset Information

Validation of a low-cost, carbon dioxide-based cryoablation system for percutaneous tumor ablation.


ABSTRACT: Breast cancer rates are rising in low- and middle-income countries (LMICs), yet there is a lack of accessible and cost-effective treatment. As a result, the cancer burden and death rates are highest in LMICs. In an effort to meet this need, our work presents the design and feasibility of a low-cost cryoablation system using widely-available carbon dioxide as the only consumable. This system uses an 8-gauge outer-diameter needle and Joule-Thomson expansion to percutaneously necrose tissue with cryoablation. Bench top experiments characterized temperature dynamics in ultrasound gel demonstrated that isotherms greater than 2 cm were formed. Further, this system was applied to mammary tumors in an in vivo rat model and necrosis was verified by histopathology. Finally, freezing capacity under a

SUBMITTER: Surtees B 

PROVIDER: S-EPMC6608927 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature